Abilash Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.29 M
- Company Age 43 Year, 8 Months
- Last Filing with ROC 31 Mar 2011
- Open Charges ₹ 0.65 M
About Abilash Pharma
Abilash Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 June 1981 and has a history of 43 years and eight months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2011. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.29 M.
The company currently has active open charges totaling ₹0.65 M.
Bart Gayathri and Sethuraman Bart serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231TN1981PTC008794
-
Company No.
008794
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Jun 1981
-
Date of AGM
30 Sep 2011
-
Date of Balance Sheet
31 Mar 2011
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Abilash Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sethuraman Bart
|
Managing Director | 14-Jun-1981 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Bart Gayathri
|
Director | 14-Jun-1981 | Current |
Financial Performance of Abilash Pharma.
Enhance accessibility to Abilash Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abilash Pharma?
Unlock access to Abilash Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.65 M
₹0
Charges Breakdown by Lending Institutions
- The Vysya Bank Ltd : 0.06 Cr
- Canara Bank : 0.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 May 1999 | The Vysya Bank Ltd | ₹0.08 M | Open |
| 28 Oct 1997 | The Vysya Bank Ltd | ₹0.50 M | Open |
| 10 Jul 1984 | Canara Bank | ₹0.03 M | Open |
| 10 Jul 1984 | Canara Bank | ₹0.03 M | Open |
| 10 Mar 1984 | Canara Bank | ₹0.03 M | Open |
How Many Employees Work at Abilash Pharma?
Unlock and access historical data on people associated with Abilash Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abilash Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abilash Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
